When to Seek a Second Opinion
- Many major cancer organizations, including Leukemia & Lymphoma Society (LLS) and National Comprehensive Cancer Network (NCCN), encourage patients to seek out second opinions for chronic lymphocytic leukemia (CLL) because multiple effective treatment options exist and picking a path can feel complex.
- Treatment decisions differ depending on whether a patient is starting frontline therapy or navigating relapsed/refractory CLL, where clinical trials and next‑generation agents may also be considered.
- “If there’s uncertainty or if patients are wanting to consider other options or weighing a challenging decision … I always encourage patients to consider a second opinion,” Dr. Cole Sterling, an oncologist who specializes in hematologic malignancies at Johns Hopkins Medicine, tells SurvivorNet.
- CLL typically progresses slowly, which gives most patients more time to gather information, consult another specialist, and make a confident, informed decision about their next steps.
According to Dr. Cole Sterling, an oncologist who specializes in hematologic malignancies at Johns Hopkins Medicine, the answer is often yes, particularly if patients feel uncertain or are weighing a difficult choice.
Read MoreFrontline Treatment: Starting Therapy
Treatment options will defer depending on whether you are getting frontline therapy (your first treatment) or a therapy for relapsed/refractory CLL (after the disease returns or stops responding to treatment).In the frontline setting, Dr. Sterling explains, “We have very effective therapies and good options, and it really is a matter of finding the right fit for each individual patient.”
Frontline CLL treatment today typically includes drugs such as:
- BTK inhibitors (acalabrutinib, zanubrutinib)
- Venetoclax‑based time‑limited regimens
- Anti‑CD20 antibodies (e.g., obinutuzumab)
These therapies have strong evidence supporting their effectiveness and safety.
Expert Resources for CLL Patients
- Changing the Way CLL is Treated: What are BTK Inhibitors?
- Determining When CLL Treatment is Needed
- Do I Need A Stem Cell Transplant For CLL?
- BTK Inhibitors: Finding The Right Fit For Chronic Lymphocytic Leukemia (CLL) Patients
- FDA Approves New All-Oral Treatment Option For CLL: What This Means For Patients
Since several good options exist — and each has different schedules, side‑effect profiles, and lifestyle considerations — a second opinion can help patients feel confident in their choice.
“If patients are struggling to really decide what the right fit for them is … it’s always a good idea to get a second opinion just to talk through and get another perspective,” Dr. Sterling says.
When Treatment Choices Become More Complex
Once patients move beyond frontline therapy, decision‑making becomes more nuanced, Dr. Sterling explains.
“In the second-line setting or later … the question becomes, do we consider things like clinical trials? Are there other options available?” Dr. Sterling said.
In second‑line and third‑line treatment, patients often still have strong standard‑of‑care options, including:
- Switching to a different BTK inhibitor
- Venetoclax‑based therapy
- Non‑covalent BTK inhibitors (such as pirtobrutinib)
- Clinical trials exploring new combinations or next‑generation agents
Clinical trials are particularly important in later lines of therapy. Many current studies are testing options like novel BTK inhibitors, CAR T-cell therapy, and combination regimens.
Dr. Sterling notes that these are exactly the situations where a second opinion can be most helpful.
“We want patients to be comfortable with their decisions and to be fully informed to be able to make a good decision for themselves,” he adds.
CLL Usually Allows Time to Explore Options
One reassuring aspect of CLL is its pace. Unlike many fast‑moving cancers, CLL often progresses slowly enough to allow thoughtful decision‑making.
“Fortunately, CLL is one of those diseases that the timeline generally allows for this … thinking through what will be next steps and next options when needed,” Dr. Sterling explains.
This means patients can take the time to gather information, review clinical trial options, and consult another specialist if needed.
Patients may want to seek a second opinion when
- They feel uncertain about their treatment options
- They’re choosing between multiple effective frontline therapies
- Their CLL has relapsed or become refractory
- They’re considering clinical trials
- They want reassurance before making a major decision
A second opinion can provide clarity, confidence, and peace of mind.
Why Self-Advocacy Matters
When patients actively advocate for their health, it can lead to earlier diagnoses, broader treatment options, and ultimately better outcomes — especially when initial symptoms are overlooked or dismissed.
Part of this advocacy means not settling for a single medical opinion. Persistence matters: revisiting your doctor, pushing for answers, and seeking additional perspectives from other healthcare providers can be crucial steps in the journey.
WATCH: The value of getting a second opinion
Questions To Ask Your Doctor
- What are my treatment options and can we review pros and cons of each?
- Are there any clinical trials I should consider?
- Are there any additional specialists you recommend speaking to?
- What are my options if I can’t tolerate the first treatment?
Learn more about SurvivorNet's rigorous medical review process.
